These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21793478)

  • 1. 'Withdrawal neuroleptic malignant syndrome': a phantom explanatory cause for a fatality.
    Gillman PK
    Med Sci Law; 2011 Apr; 51(2):122-3; author reply 124. PubMed ID: 21793478
    [No Abstract]   [Full Text] [Related]  

  • 2. An unrecognised case of withdrawal neuroleptic malignant syndrome: a case report.
    Ball H; de Waal H; Craig K
    Med Sci Law; 2009 Oct; 49(4):298-300. PubMed ID: 20025106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Akinetic crisis, acute akinesia, neuroleptic malignant-like syndrome, Parkinsonism-hyperpyrexia syndrome, and malignant syndrome are the same entity and are often independent of treatment withdrawal.
    Thomas A; Onofrj M
    Mov Disord; 2005 Dec; 20(12):1671; author reply 1671-2. PubMed ID: 16149099
    [No Abstract]   [Full Text] [Related]  

  • 4. An uncommon adverse effect of levodopa withdrawal in a patient taking antipsychotic medication: neuroleptic malignant-like syndrome.
    Man SP
    Hong Kong Med J; 2011 Feb; 17(1):74-6. PubMed ID: 21282831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic malignant syndrome following levomepromazine discontinuation.
    Tanii H; Saka K; Inoue K; Okada M
    J Neuropsychiatry Clin Neurosci; 2010; 22(2):E16. PubMed ID: 20463130
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuroleptic malignant syndrome related to a switch to perospirone and anticholinergic withdrawal.
    Tanii H; Fujita K; Okazaki Y
    Am J Psychiatry; 2006 Mar; 163(3):547-8. PubMed ID: 16513884
    [No Abstract]   [Full Text] [Related]  

  • 7. [The neuroleptic malignant syndrome].
    Duarte J; García Viejo MA; García Miguel FJ; Sempere AP
    Med Clin (Barc); 1994 Oct; 103(14):558. PubMed ID: 7799673
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuroleptic malignant syndrome and clozapine withdrawal at the same time?
    Margetić B; Aukst-Margetić B
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):145-7. PubMed ID: 15610957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic malignant syndrome after imipramine withdrawal.
    Merriam AE
    J Clin Psychopharmacol; 1987 Feb; 7(1):53-4. PubMed ID: 3818994
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuroleptic malignant syndrome (NMS) on neuroleptic withdrawal.
    Corrigan FM; Coulter F; Mackay AV
    Acta Psychiatr Scand; 1990 Sep; 82(3):268-9. PubMed ID: 1978961
    [No Abstract]   [Full Text] [Related]  

  • 11. Case files of the program in medical toxicology at brown university: amantadine withdrawal and the neuroleptic malignant syndrome.
    Brantley E; Cohn J; Babu K
    J Med Toxicol; 2009 Jun; 5(2):92-8. PubMed ID: 19415596
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuroleptic malignant syndrome precipitated by haloperidol following clozapine discontinuation.
    Mendhekar DN; Jiloha RC
    Aust N Z J Psychiatry; 2005 Oct; 39(10):947-8. PubMed ID: 16168023
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuroleptic malignant syndrome postoperative onset due to levodopa withdrawal.
    Young CC; Kaufman BS
    J Clin Anesth; 1995 Dec; 7(8):652-6. PubMed ID: 8747565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroleptic malignant syndrome precipitated by promethazine and lorazepam.
    Duggal HS
    Aust N Z J Psychiatry; 2001 Apr; 35(2):250-1. PubMed ID: 11284912
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuroleptic malignant syndrome associated with bromocriptine withdrawal in Parkinson's disease--a case report.
    Wu YF; Kan YS; Yang CH
    Gen Hosp Psychiatry; 2011; 33(3):301.e7-8. PubMed ID: 21601731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olanzapine induced neuroleptic malignant syndrome--a case review.
    Kogoj A; Velikonja I
    Hum Psychopharmacol; 2003 Jun; 18(4):301-9. PubMed ID: 12766935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case report of neuroleptic malignant syndrome associated with withdrawal from amantadine.
    Simpson DM; Davis GC
    Am J Psychiatry; 1984 Jun; 141(6):796-7. PubMed ID: 6145359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuroleptic malignant syndrome: a review of literature].
    Crespo Facorro B; Carbonell Masia C
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(5):273-8. PubMed ID: 8553925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuroleptic malignant syndrome in users of risperidone].
    Gerritsen AA; de Jonghe-Rouleau AP; Stienstra-Liem LH
    Ned Tijdschr Geneeskd; 2004 Sep; 148(37):1801-4. PubMed ID: 15495506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of neuroleptic malignant syndrome during simultaneous amoxapine treatment and alprazolam discontinuation.
    Burch EA; Downs J
    J Clin Psychopharmacol; 1987 Feb; 7(1):55-6. PubMed ID: 3818996
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.